RAC 1.91% $1.60 race oncology ltd

Ann: Race Develops Improved IV Formulation of Zantrene, page-16

  1. 2,749 Posts.
    lightbulb Created with Sketch. 2837
    great insight, wasn’t aware of home infusion this is very interesting. Oral formulation is in the works so should provide holistic patient options.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.60
Change
0.030(1.91%)
Mkt cap ! $270.9M
Open High Low Value Volume
$1.59 $1.62 $1.57 $161.8K 102.0K

Buyers (Bids)

No. Vol. Price($)
1 5431 $1.58
 

Sellers (Offers)

Price($) Vol. No.
$1.60 2319 1
View Market Depth
Last trade - 13.27pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.